Big Pharma Sharma

Big Pharma Sharma

Share this post

Big Pharma Sharma
Big Pharma Sharma
The Renaissance of Psychedelics: Charting New Paths in Mental Health Treatment

The Renaissance of Psychedelics: Charting New Paths in Mental Health Treatment

Below I venture into the development landscape of psychedelics and pyschedelic-based treatments for psychiatric diseases

Big Pharma Sharma's avatar
Big Pharma Sharma
May 21, 2024
∙ Paid
2

Share this post

Big Pharma Sharma
Big Pharma Sharma
The Renaissance of Psychedelics: Charting New Paths in Mental Health Treatment
6
1
Share
a group of mushrooms growing out of a rock
Photo by Igor Omilaev on Unsplash

Introduction

There has been a buzz in the pharma world about psychedelic compounds. Once on the fringes of research, these substances are now front and center in the quest for new psychiatric treatments. Companies are diving in, enticed by the promise these molecules hold, looking to harness the psychedelic properties of these molecules to treat psychiatric diseases with high unmet need. But, as with any burgeoning field, the road ahead is filled with both opportunities and obstacles.

Overview of the Psychedelics Development Landscape

Join your colleagues who are getting smarter each week by tapping into insider analysis and insights for just $10/month. You can probably even expense it through your company ;-)

Keep reading with a 7-day free trial

Subscribe to Big Pharma Sharma to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Big Pharma Sharma LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share